Wednesday, May 27, 2015

Cancer Research:Nano-capsules designed for diagnosing malignant tumors ♦ association between exposure to aflatoxin and gallbladder cancer ♦ Response in patients with metastatic melanoma


Nano-capsules designed for diagnosing malignant tumors Researchers have developed adaptable nanocapsules that can help in the diagnosis of glioblastoma cells -- a highly invasive form of brain tumor
Investigational immunotherapy treatment shows durable response in patients with metastatic melanoma Advanced-stage melanoma patients have significant improvement in durable response rate when treated with a genetically-modified form of a herpes virus, whose native form causes the common cold sore, new research shows.
Study suggests using excess stress to kill therapy resistant breast cancer Maxing out the inherently stressed nature of treatment-resistant breast cancer cells thwarts their adaptive ability to evolve genetic workarounds to treatment, according to a study. Looking at tumor progression as essentially an evolutionary process, researchers highlight the feasibility of maximizing cell stress by inhibiting adaptive pathways to cause cell death
Clinical trial reduces stress of cancer caregivers A randomized control trial demonstrates an intervention that successfully reduces the stress of caregivers in the context of cancer patients treated with stem cell transplantation. The study enrolled 148 caregivers of allogeneic hematopoietic stem cell (Allo-HSCT) patients

Study finds association between exposure to aflatoxin and gallbladder cancer In a small study in Chile that included patients with gallbladder cancer, exposure to aflatoxin (a toxin produced by mold) was associated with an increased risk of gallbladder cancer. In Chile, gallbladder cancer is a leading cause of cancer death in women.

No comments:

Post a Comment